Casi Pharmaceuticals Inc (CASI) Live Share Price, Invest From India

Casi Pharmaceuticals Inc Stock Performance

as on December 20, 2025 at 2:28 am IST

Day's High
$0.81
Day's Price Range
$0.88
$0.81
8.64%
Upside
52 Week's Low
52 Week's High
$0.8
52-Week Price Range
$3.47
$0.81
1.10%
Downside
328.40%
Upside

Casi Pharmaceuticals Inc share price movements today

Previous Close: $0.83
Open: $0.88
Volume: 78.8K
Day's Low - High: $0.81 - $0.88
52 Week Low - High: $0.8 - $3.47

Casi Pharmaceuticals Inc Historical Returns

1 Month Return: -31.93 %
3 Month Return: -54.49 %
1 Year Return: -69.43 %
3 Year Return: -52.63 %
5 Year Return: -97.09 %

Casi Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Casi Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.9M

EPS (TTM)

-2.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-42.3M

Revenue (TTM)

26.8M

Profit Margin

-183.96%

Return On Equity TTM

-1094.50%

Casi Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Casi Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Casi Pharmaceuticals Inc	BUY	$12.9M	-97.09%	NA	-183.96%
Insmed Incorporated	BUY	$37.3B	371.01%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$52.3B	181.08%	1237.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$114.7B	92.72%	31.44	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$79.4B	53.93%	17.95	32.13%

Stock Returns calculator for Casi Pharmaceuticals Inc Stock including INR - Dollar returns

The Casi Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Casi Pharmaceuticals Inc investment value today

Current value as on today

₹35,798

Returns

₹64,202

(-64.2%)

Returns from Casi Pharmaceuticals Inc Stock

₹69,434 (-69.43%)

Dollar Returns*

₹5,231 (+5.23%)

Analyst Recommendation on Casi Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Casi Pharmaceuticals Inc. Average target price of $4

Casi Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Casi Pharmaceuticals Inc.

What analysts predicted

79.75%UPSIDE

Target Price

Current Price

$0.81

Analyzed by

7 Analysts

Target

$4.00

Casi Pharmaceuticals Inc target price $4, a slight upside of 79.75% compared to current price of $0.81. According to 7 analysts rating.

Casi Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Casi Pharmaceuticals Inc Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 21, 2025 to December 21, 2025

Change:62% versus previous 30 day period

Casi Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	9	8	6	3	3	7	13	6	4	3
Gross Profit	5	5	4	1	2	4	3	3	2	0
Operating Income	-8	-5	-4	-9	-8	-8	-12	-10	-11	-10
EBITDA	-7	-4	-3	-8	-8	-7	-9	-10	-10	-10
Interest Expense	-	-	-	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-10	-4	-5	-9	-6	-7	-14	-10	-11	-10
Income Tax Expense	0	0	0	0	-	1	0	-	2	-
Net Income	-10	-4	-6	-9	-6	-8	-14	-10	-13	-10
Net Profit Margin	-104.27%	-52.44%	-88.09%	-279.50%	-175.04%	-107.72%	-107.59%	-172.28%	-320.36%	-353.92%

Casi Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	4	15	30	43	33	28
Gross Profit	0	0	0	-1	0	5	17	27	20	11
Operating Income	7	9	-10	-26	-39	-52	-41	-26	-25	-39
EBITDA	-7	-9	-10	-25	-37	-31	-33	-24	-21	-34
Interest Expense	0	0	0	0	1	-	5	0	0	0
Depreciation	-	-	0	1	2	3	1	2	3	2
Income Before Tax	-7	-9	-10	-27	-45	-47	-35	-38	-26	-38
Income Tax Expense	0	0	0	0	6	15	1	1	0	1
Net Income	-7	-9	-10	-27	-45	-48	-36	-41	-26	-39
Net Profit Margin	-15104.01%	0.00%	0.00%	0.00%	-1098.09%	-318.92%	-121.50%	-95.14%	-79.51%	-137.57%

Casi Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-4	-6	-9	-6	-8	-14	-10	-13	-10
Operating Cash Flow	-	-	-	-	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-	-	-	-	-
Change in Cash	3	-2	-4	-2	7	-3	-2	-4	-2

Casi Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-9	-10	-27	-45	-47	-35	-40	-26	-39
Operating Cash Flow	-6	-6	-28	-23	-25	-26	-21	-19	-29
Investing Cash Flow	0	0	-21	-28	-20	-20	31	-9	11
Financing Cash Flow	28	23	92	22	47	29	-3	0	15
Change in Cash	21	16	40	-30	3	-18	8	-30	-3

Global Institutional Holdings in Casi Pharmaceuticals Inc

Funds	Holdings
VR Adviser, LLC	6.37%
Foresite Capital Management VI LLC	5.08%
Woodline Partners LP	1.07%
Wellington Shields Capital Mgmt LLC	0.59%
ADAR1 Capital Management LLC	0.28%

See all

Insights on Casi Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -13.37M → -10.88M (in $), with an average increase of 22.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 217.6%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 779.0% return, outperforming this stock by 829.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 13.35M → 3.07M (in $), with an average decrease of 37.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CASI stock has moved down by -34.1%

About Casi Pharmaceuticals Inc

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.

Organisation	Casi Pharmaceuticals Inc
Headquarters	1701-1702, China Central Office Tower 1, Beijing, China, 100025
Industry	Health Technology
CEO	Mr. David A. Cory M.B.A., R.Ph.
E-voting on shares	Click here to vote

Key Management of Casi Pharmaceuticals Inc

Name	Title
Dr. Wei Zhang Ph.D.	Senior Vice President
Mr. David A. Cory M.B.A., R.Ph.	CEO & Director
Ms. Kun Qian	VP & Global Controller
Ms. Chunhua Wang	Chief Operating Officer
Ms. Wei Gao	General Counsel
Dr. James E. Goldschmidt Ph.D.	Chief Business Officer
Mr. Hai Huang	Chief Commercial Officer & GM
Dr. Alexander A. Zukiwski M.D.	Executive VP & Chief Medical Officer

FAQs

What is Casi Pharmaceuticals Inc share price today?

Casi Pharmaceuticals Inc share price today is $0.81 as on December 20, 2025 at 2:28 am IST at the close of the market. Casi Pharmaceuticals Inc share today touched a day high of $0.88 and a low of $0.81.

What is the 52 week high and 52 week low for Casi Pharmaceuticals Inc share?

Casi Pharmaceuticals Inc share touched a 52 week high of $3.47 on December 26, 2024 and a 52 week low of $0.8 on December 10, 2025. Casi Pharmaceuticals Inc stock price today i.e. December 20, 2025 at 2:28 am IST is closed at $0.81,which is 76.66% down from its 52 week high and 1.11% up from its 52 week low.

What is Casi Pharmaceuticals Inc's market capitalisation today?

Casi Pharmaceuticals Inc market capitalisation is $0.00T as on December 20, 2025 at 2:28 am IST.

How to invest in Casi Pharmaceuticals Inc Stock (CASI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Casi Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Casi Pharmaceuticals Inc Shares that will get you 1.8519 shares as per Casi Pharmaceuticals Inc share price of $0.81 per share as on December 20, 2025 at 2:28 am IST.

What is the minimum amount required to buy Casi Pharmaceuticals Inc Stock (CASI) from India?

Indian investors can start investing in Casi Pharmaceuticals Inc (CASI) shares with as little as ₹89.552 or $1 (as of December 21, 2025 at 11:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Casi Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on December 21, 2025 at 11:42 pm IST). Based on Casi Pharmaceuticals Inc share’s latest price of $0.81 as on December 20, 2025 at 2:28 am IST, you will get 12.3457 shares of Casi Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Casi Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Casi Pharmaceuticals Inc stock has given -97.09% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?